BI Presents a Six-Part Webinar Series
|
|
|
|
The COVID-19 pandemic has and will continue to cause a historic shift in the economic landscape across the globe. For cannabis companies,
this comes at a time many were already navigating historic shifts in cannabis legalization and the challenges facing a nascent and fast-emerging industry. This panel discussion will examine the new challenges and realities for cannabis businesses in the post-COVID-19
economy, while exploring how risk management practices and insurance markets can and will shape the industry’s response.
|
Hemp and CBD exploded in 2019 after passage of the 2018 Farm Bill. Due to the perceived safety of this new part of the cannabis economy,
manufacturers, distributors, retailers and insurers are quickly entering the space. Ironically, however, regulatory risks and civil tort exposure are arguably higher for operating in and insuring the hemp and CBD markets compared to the federally illegal marijuana
sector. From ongoing hemp testing and transportation challenges to evolving FDA guidance, inconsistent state laws and a new wave of consumer class actions, this panel of experienced hemp/CBD operators and risk managers will identify how these risks have grown
and what businesses and insurers are doing to continue to operate in consumer markets that will continue to grow.
|
The cannabis marketplace continues to grow in size and complexity. New products containing THC, CBD, CBG and lesser-known cannabinoids are
hitting the shelves in existing and new state markets. Mitigating risk in this environment means navigating around potential liability arising from the supply chain, distribution, marketing, labeling, testing, regulators, public affairs and communication with
consumers. This panel of cannabis operators, risk managers, scientists and insurance professionals will identify the most significant product-related risks and challenges in 2020 and beyond.
|
The cannabis insurance market has seen solid growth over the past year with the exception of specialty lines which has lagged behind other
coverages. Now more than ever, the industry needs broader coverage and higher limits for D&O, E&O, EPLI and Cyber risks. This panel of insurance experts will shed light on the challenges of cannabis specialty lines underwriting and pricing, the volatile claims
environment and how these markets will likely develop.
|
Join us for an expert panel discussion on the benefits of cannabinoid medicine; what we know and what we don’t know about THC and CBD; standards
of practice for healthcare providers in recommending cannabis and standards of practice for dispensaries; and what every health care provider needs to know, whether they recommend (prescribe) cannabis or not.
|
Come learn the ‘why’s’ behind the questions underwriters ask and how we, as a community, can establish best practices that meet the desired
goals for all parties along the supply chain.
|
|
|
*Registrations are limited
After registering, you will receive a confirmation email containing information about joining the webinar.
View System Requirements
|
|
|
THANK YOU TO OUR SPONSORS
FOUNDING PARTNER
|
|
|
Most industry professionals qualify for free membership.
|
|
|
Save the Date or register for upcoming events, nominations and webinars.
|
|
|
|
Business Insurance, PO Box 1010, Greenwich, Connecticut 06836, United States
Manage
preferences
|
|
|
|
